Municipal Employees Retirement System of Michigan Invests $766,000 in Integra Lifesciences Holdings Corp (IART) Stock

Municipal Employees Retirement System of Michigan acquired a new position in shares of Integra Lifesciences Holdings Corp (NASDAQ:IART) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 16,980 shares of the life sciences company’s stock, valued at approximately $766,000.

Other large investors also recently modified their holdings of the company. Oregon Public Employees Retirement Fund increased its holdings in shares of Integra Lifesciences by 4,410.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 1,254,051 shares of the life sciences company’s stock valued at $28,000 after acquiring an additional 1,226,245 shares during the period. Enlightenment Research LLC acquired a new position in shares of Integra Lifesciences in the 4th quarter valued at $32,000. Legacy Financial Advisors Inc. acquired a new position in shares of Integra Lifesciences in the 4th quarter valued at $33,000. Fort L.P. acquired a new position in shares of Integra Lifesciences in the 4th quarter valued at $34,000. Finally, Captrust Financial Advisors increased its holdings in shares of Integra Lifesciences by 43.6% in the 4th quarter. Captrust Financial Advisors now owns 2,330 shares of the life sciences company’s stock valued at $105,000 after acquiring an additional 707 shares during the period. Institutional investors and hedge funds own 83.91% of the company’s stock.

Several equities analysts have issued reports on the stock. Cantor Fitzgerald reissued a “hold” rating and issued a $50.00 price objective on shares of Integra Lifesciences in a research note on Thursday, February 21st. BidaskClub cut shares of Integra Lifesciences from a “hold” rating to a “sell” rating in a research note on Tuesday, April 16th. ValuEngine cut shares of Integra Lifesciences from a “hold” rating to a “sell” rating in a research note on Thursday. Oppenheimer reissued a “buy” rating on shares of Integra Lifesciences in a research note on Tuesday, March 19th. Finally, Zacks Investment Research raised shares of Integra Lifesciences from a “sell” rating to a “hold” rating in a research note on Monday, February 18th. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and five have issued a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $60.67.

Shares of NASDAQ IART traded up $0.99 during trading on Friday, hitting $51.14. 843,018 shares of the company were exchanged, compared to its average volume of 432,992. The firm has a market capitalization of $4.36 billion, a P/E ratio of 21.13, a PEG ratio of 1.51 and a beta of 0.96. Integra Lifesciences Holdings Corp has a 1 year low of $42.14 and a 1 year high of $67.50. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.88 and a current ratio of 2.95.

Integra Lifesciences (NASDAQ:IART) last issued its earnings results on Thursday, February 21st. The life sciences company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.62 by $0.03. Integra Lifesciences had a net margin of 4.13% and a return on equity of 16.02%. The company had revenue of $383.30 million for the quarter, compared to analyst estimates of $382.33 million. During the same period in the previous year, the firm earned $0.64 EPS. The business’s revenue was up 4.0% on a year-over-year basis. On average, sell-side analysts forecast that Integra Lifesciences Holdings Corp will post 2.68 earnings per share for the current fiscal year.

In related news, major shareholder Richard E. Caruso sold 30,128 shares of the business’s stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $56.06, for a total value of $1,688,975.68. Following the sale, the insider now directly owns 143,384 shares in the company, valued at approximately $8,038,107.04. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Rhonda Germany Ballintyn acquired 1,933 shares of the firm’s stock in a transaction that occurred on Thursday, March 14th. The stock was acquired at an average price of $56.08 per share, for a total transaction of $108,402.64. Following the completion of the transaction, the director now directly owns 3,665 shares in the company, valued at $205,533.20. The disclosure for this purchase can be found here. 4.50% of the stock is owned by insiders.

ILLEGAL ACTIVITY WARNING: “Municipal Employees Retirement System of Michigan Invests $766,000 in Integra Lifesciences Holdings Corp (IART) Stock” was posted by Baseball Daily News and is the sole property of of Baseball Daily News. If you are viewing this news story on another domain, it was copied illegally and reposted in violation of US and international copyright legislation. The original version of this news story can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/municipal-employees-retirement-system-of-michigan-buys-shares-of-16980-integra-lifesciences-holdings-corp-iart.html.

Integra Lifesciences Company Profile

Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies.

Read More: How to execute a trade ex-dividend strategy?

Institutional Ownership by Quarter for Integra Lifesciences (NASDAQ:IART)

Receive News & Ratings for Integra Lifesciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integra Lifesciences and related companies with MarketBeat.com's FREE daily email newsletter.